Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine 0.1% vs 0.2% in Glaucoma or Ocular Hypertension
NCT00652483Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine in Glaucoma, ocular hypertension, sponsored by Allergan. Started May 2003; status: completed.
02
Drugs
brimonidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00652483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652483.